4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015811
EVP and Chief Legal Officer sold 2,886 shares at $66.62 ($192,265)
- EVP and Chief Legal Officer acquired 14,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Sale : show line 1 in the form | −2,886 | $66.62 | $192,265 | 25,472 | D |
| 2022-03-01 | Grant or award : show line 2 in the form | +14,000 | 39,578 | D | ||
| Open-market sales · 2,886 sh · avg $66.62 · $192,265 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +24,900 | 24,900 | D |
Loading xslF345X03/doc4.xml…